A systematic review finds that gut microbes and metabolites may shape the liver immune environment associated with immunotherapy response in hepatocellular carcinoma, but clinical evidence remains ...
Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and ...
LONDON--Arini, an alternative asset manager with $22 billion in assets under management as of 31 August 2026, today announces the final close of Arini Direct Lending Fund I. The Fund and related ...
Pantheon Global Secondaries Fund VIII (PGSF VIII) and related vehicles held its final closing at $6bn, exceeding its $3.5bn target by 71% The ...
A review of preclinical evidence finds that nanomaterials can improve mitochondrial targeting, organelle protection and ...
ADB unveils a five-year strategy (2026-2030) to boost resilience and economic opportunities in 12 Pacific island countries ...
Sincerely, L. Kevin Kelly Chairman and Chief Executive Officer Cycurion, Inc.
Unlike general-purpose LLMs, point solutions or agencies, Different builds and runs the whole campaign in one closed loop. It ...
Directional trading refers to strategies based on the investor’s view of the up or down movement of the broader market or a ...
In today's turbulent business environment, the speed of corporate decision-making is directly linked to the "probability of ...
Akari's CEO outlines plans for AKTX-101 and the importance of novel ADC payloads in cancer treatment advancements.
Early clinical data from the Phase 1 theranostic trial support the advancement of ATNM-400 as a non-PSMA targeted alpha therapy for metastatic castration-resistant prostate cancer Evaluation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results